NSC |
Compound |
Enrichment |
Correlation |
NSC 289922 |
Phosphonium, triphenyl-1-propenyl-, bromide, (E)- (9CI) |
0.00313644776247642 |
0.22137535 |
NSC 624659 |
ANTINEOPLASTIC-624659 |
0.00313644776247642 |
0.38819038 |
NSC 625505 |
Null |
0.00313644776247642 |
0.21884509 |
NSC 666667 |
Null |
0.00347157511980527 |
0.19989335 |
NSC 709341 |
Null |
0.00347157511980527 |
-0.10666316 |
NSC 132791 |
Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo |
0.00397405528023193 |
-0.054150284 |
NSC 149765 |
1,4-Pentanediamine, N4-(6-methoxy-8-quinolinyl)-, phosphate (1:2) (9CI) |
0.00397405528023193 |
-0.010261842 |
NSC 616960 |
2[5H]-Furanone, 5-[(.beta.-D-glucopyranosyloxy)methyl]-,(S)- (9CI) |
0.00397405528023193 |
0.20807679 |
NSC 625624 |
7,12-Epidioxybenz[a]anthracene, 7,12-dihydro-7-methyl- |
0.00397405528023193 |
0.38512518 |
NSC 682769 |
5H-Pyrido[3,2-d][2]benzazepin-6(7H)-one, 4-(3,4-dimethoxyphenyl)-2-phenyl- |
0.00397405528023193 |
-0.20891033 |